RNS Number : 7008K
JPMorgan Emerging EMEA Securities
01 November 2024
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN EMERGING EUROPE, MIDDLE EAST & AFRICA SECURITIES PLC

(the 'Company')

 

Compliance with Market Abuse Regulation

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

Information disclosed in accordance with Market Abuse Regulation Article 19, paragraph 11

 

The Company announces that it is satisfied that all inside information which the Directors and the Company may have in the period leading up to the announcement of its results for the year ended 31st October 2024 has previously been, and will continue to be, notified via a regulatory information service. Therefore the Company is not prohibited from dealing in its own securities.

 

The mandatory closed period under MAR will commence on 16th December 2024 and will last until the results in respect of the year ended 31st October 2024 are published.      

 

If in the period leading up to the announcement of the year-end results the Directors of the Company come into the possession of any inside information, this will be notified to the London Stock Exchange without delay and before any such transactions are undertaken.

 

 

 

 

JPMorgan Funds Limited - Secretary

1st November 2024

 

 

For further information, please contact:

 

Paul Winship

JPMorgan Funds Limited                                            

0800 20 40 20 (or +44 1268 44 44 70)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDBIBGDGSB